By vgreene, 8 March, 2019 If pt ≥65 yo: consider coexisting conditions/cognition/functional status w/ care to avoid symptomatic hyperglycemia and minimize risk of acute hyperglycemia complications [B]11
By vgreene, 8 March, 2019 Efficacy hypoglycemia risk 4 and wt concerns to consider when selecting antihyperglycemic tx
By vgreene, 8 March, 2019 If HbA1c still above target, choose agents demonstrating CV safety (but avoid TZD in the setting of HF):